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Teske E, Knapen F van, Beijer EGM, Slappendel RJ: Risk of infection with leish-
mania spp. in the canine population in the Netherlands. Acta vet. scand. 2002, 43,
195-201. – The dog is the main reservoir of Leishmania infantum, the causative agent
of visceral leishmaniasis (VL) in humans in Southern Europe. In order to identify the
risk of dogs from a Leishmania non-endemic area traveling to a Leishmania-endemic
area becoming infected and the risk of transmitting infection to humans in non-endemic
areas an investigation was performed, in which the results of a questionnaire were com-
bined with the results of a serologic survey.
The questionnaire was sent to 1478 at random chosen families in the Netherlands. Of
the 59.0% responders 28.0% had one or more dogs and 4.8% of these dogs had visited
Southern Europe during the summer period of that year. On a total population of
1,200,000 dogs in the Netherlands, this means that each year some 58,000 dogs are at
risk of being exposed to a Leishmania infection in Southern Europe.
During the period 1990-1992 blood was collected for serology in 1911 dogs presented
to the Utrecht University Clinic because of clinical problems not related to leishmania-
sis, of which 434 had been in Southern Europe in the foregoing years. None was sero-
logically positive. From these data it can be deduced that the highest chance to obtain
leishmaniasis during a vacation in Southern Europe is mathematically less than 1/434 or
less than 0.23%. Serology was also performed during the period 1989-1993 in 597 dogs
that had been in Southern Europe and were suspected of leishmaniasis. Titers were pos-
itive in 145 of these samples. Sixty-four of these dogs were born in the Mediterranean
and had been imported into the Netherlands. Excluding these imported dogs, it was cal-
culated that at least 0.027% of the 58,000 dogs yearly taken to Southern Europe during
holidays become infected with Leishmania. In order to establish the risk of disease
transmission for people in close contact with an infected dog, serum samples of owners
and house mates of 37 dogs with leishmaniasis were tested. All 112 sera tested negative.
It was concluded that the risk to get leishmaniasis was between 0.027% and 0.23% for
the dog when taken to Southern Europe during vacation, and that the risk for owners in
non-endemic areas to get leishmaniasis from an infected dog is minimal.
Leishmaniasis; dog; non-endemic; infection risk; questionnaire; serology.
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Introduction
Leishmania infantum is the causative agent of
visceral leishmaniasis (VL) in humans in
Southern Europe. The dog is the main reservoir
of this parasite (Bettini & Gradoni 1986). In-
fected dogs may develop VL themselves and
are a potential source of contamination to both
other dogs and man. Sandﬂies are essential in
the transmission of the disease. The prevalence
of leishmania infection in endemic areas in the
Mediterranean area varies from one country to
another. The prevalence in dogs has been re-
ported to rarely exceed 10%, while in the sameareas contamination of human native inhibi-
tants does not exceed 1%-2% (Slappendel
1988). No breed, age or sex predeliction has
been reported in Europe. In Northern Europe,
where appropriate sandﬂies are lacking, canine
VL is diagnosed almost exclusively in animals
that have traveled or resided in Leishmania-en-
demic countries. 
Clinical signs of leishmaniasis in the dog may
vary and may develop in a period of months to
several years after the infection. The most com-
mon clinical signs are decreased endurance,
weight loss, lymphadenopathy, and skin prob-
lems. The skin problems are variable, but usu-
ally include hyperkeratosis, presenting as ex-
cessive scaling of the epidermis, especially on
the nose, around the eyes and at the pinna, and
thickening, depigmentation and chapping of the
nozzle and the foot pad. Systemic signs may in-
clude hemorrhagic diathesis, paraglobuline-
mia, uremia and anaemia (Slappendel & Ferrer
1998). 
Many reports of canine leishmaniasis in non-
endemic countries have been published (Bind-
seil et al. 1985, Slappendel 1988, Bravo et al.
1993, Edelhofer et al. 1995, Gothe 1990, Gothe
et al. 1997, Johansson et al. 1998 ). Its preva-
lence in these sandﬂy-free regions is unknown,
but may be of interest to veterinarians, pharma-
ceutical industries, and policy makers in the
sector of public health. It may also be of inter-
est to dog owners and veterinarians who want to
know what risk a dog runs to obtain leishmani-
asis during a temporary stay in an endemic
country. In addition, people residing in non-en-
demic areas may want information about the
possible infectivity of dogs with VL to people
and other dogs in the absence of sandﬂies. In
dogs, several cases of autochthonous leishma-
niasis have been described in non-endemic
countries (Schawalder 1977, Gothe 1990, Har-
ris 1994, Diaz-Espineira & Slappendel 1997).
Disease transmission from dogs to humans in
non-endemic countries has not been described
so far.
In order to identify the risk of infection by tak-
ing dogs from a non-endemic area to a Leish-
mania-endemic area an investigation was per-
formed, in which the results of a questionnaire
were combined with the results of a serologic
survey.
Materials and methods
Questionnaire
A questionnaire was sent to 1478 randomized
families throughout the Netherlands in Novem-
ber 1989. The families were asked to indicate if
they owned any dogs and if so, how many dogs
they had. In addition, they were asked if they
had taken their dog(s) during their vacation to a
Leishmania endemic area (Dereure et al. 1999)
between April and October of that year. A map
indicating the countries of concern accompa-
nied the questionnaire.
Serology
Dogs. During the period 1990-1992 blood was
collected for serology by venepuncture from
dogs that had been referred to the Utrecht
University Clinic of Companion Animals
(UUCCA) with clinical symptoms not related
to leishmaniasis. The owner was also asked if
the dog had been in a Leishmaniaendemic area.
Samples were also obtained from dogs pre-
sented to the UUCCA that were suspected of
leishmaniasis, because of clinical signs and a
previous stay in Southern Europe with clinical
signs possibly related to leishmaniasis. In addi-
tion, blood samples were obtained from dogs
sent in by practioners to diagnose leishmaniasis
during the period 1989-1993, for Utrecht being
the only veterinary laboratorium in The Nether-
lands to determine Leishmania titers. Clinical
signs included one or more of the following:
generalized skin lesions, especially around the
eyes and on the dorsal aspect of the nose, ex-
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loss, pronounced weight loss, lymphadenopa-
thy, splenomegaly, and renal failure.
Humans. Owners and other human house
mates of dogs with VL residing in the Nether-
lands were asked to participate on a voluntary
base in this investigation. If they agreed, their
family doctor collected a blood sample for
serology on leishmaniasis. The serology was
carried out at the National Institute of Public
Health and Environmental Protection, Bil-
thoven, The Netherlands, by standard im-
munoﬂuorescence procedures, using pro-
mastigotes of various Leishmania species,
known as human pathogen (Harrith et al.
1989).
Direct agglutination test (DAT). The
DAT was performed as described previously
(Harith et al. 1989,  Oskam et al. 1996). In
short, test serum was serially diluted twofold in
V-shaped micro wells (Greiner, Frickenhausen,
Germany) with a diluent consisting of NaCl
0.9% (w/v), gelatin 0.2% (Difco Laboratories,
Detroit, Michigan) and ß-mercaptoethanol
1.56% (v/v), and subsequently incubated at
37°C for 1 h. Aliquots of freeze-dried leish-
mania antigen which had been prepared as de-
scribed by Meredith et al. (1995) were freshly
reconstituted in 5 ml normal saline (0.9%(w/v)
NaCl). Fifty µl of reconstituted antigen was
added to each well of the micro well plate con-
taining 50 µl of diluted serum. An 18-20 h in-
cubation period was employed at ambient tem-
perature before the reading of the DAT. The
titer was deﬁned as the highest dilution at which
agglutination is still visible. This agglutination
shows as blue mats or enlarged blue dots in
comparison to the compact blue dots present in
the negative control wells. The reported sensi-
tivity and speciﬁcity of this test is 100% and
98.9%, respectively (Harith et al. 1989).
Results
Of the 1478 randomized chosen families in the
Netherlands to which a questionnaire had been
forwarded, 872 (59.0%) had responded. Of
these 872 responders 244 families owned one
or more dogs (i.e. 28.0%) including a total of
270 dogs. Thirteen dogs (4.8%) had accompa-
nied their owner to Southern Europe in the fore-
going infectious period (April to October) dur-
ing a shorter or longer vacation. Extrapolated to
the 1.2 million dogs living in the Netherlands,
this means that yearly approximately 58,000
Dutch dogs visit Southern Europe, hence may
be at risk of getting a Leishmania infection.
During the period January 1990-January 1993
blood was collected for serology from 1911
dogs presented to the UUCCA which had all
kinds of different disorders but were not sus-
pected of VL. Results are presented in Table 1.
Only one dog tested Leishmania positive, even
after repeated testing. This dog had never been
in a Leishmania endemic area. Of the 1910
Leishmania negative dogs 434 dogs had been in
South Europe for some time during the 3 years
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Table 1. Results of DAT serology testing for leishmaniasis in 1911 dogs.
Clinical information No. of dogs Positive test Negative test
No symptoms of VL 1911 1 1910
- visited in endemic area 434 0 434
- not been in endemic area 577 1 576
Suspect of VL been in endemic area 597 145 452preceding the blood sampling. From these data
it can be deduced that the highest chance to ob-
tain leishmaniasis during a vacation in South-
ern Europe is mathematically less than 1/434 or
less than 0.23%.
During the period January 1989-January 1994
serology was performed in 597 dogs that had
visited Southern Europe and showed clinical
symptoms possibly related to leishmaniasis. Of
these animals, 145 dogs tested Leishmania pos-
itive. Eighty-one (56%) of these dogs (i.e. ap-
proximately 16 dogs per year) had only tem-
porarily resided abroad. The other dogs were
born in the Mediterranean and had been im-
ported into the Netherlands. Excluding this lat-
ter group of dogs from the risk calculation it can
be concluded that at least 16 (0.027%) of the
58,000 dogs yearly visiting southern Europe are
infected with Leishmania.
Anti-leishmania antibodies were assayed in 112
owners or human house mates of 37 dogs with
conﬁrmed leishmaniasis. All tested negative. 
Discussion
Little is known about the actual prevalence of
canine VL in Northern Europe. Due to the in-
creasing international tourism and migration of
people that are accompanied by pets, the num-
ber of dogs with VL in non-endemic regions is
growing and its occurrence has been reported
now in many countries which lack the appropri-
ate sandﬂy for Leishmania(Bindseil et al.1985,
Slappendel 1988, Bravo et al. 1993, Edelhofer
et al. 1995, Gothe 1990, Gothe et al. 1997, Jo-
hansson et al. 1998 ).
In the present study, some quantitative data
have been collected that may be helpful to esti-
mate the infection risk for dogs visiting a Leish-
mania endemic area. A questionnaire was sent
to 1478 randomized families of which 58% re-
sponded. This percentage is not bad for such a
questionnaire, although of course a potential
selection bias can never be excluded. Accord-
ing to this questionnaire it was calculated that
approximately 58,000 Dutch dogs, i.e. 4.8% of
the total dog population in the Netherlands,
yearly visit Southern Europe, hence may be at
risk of getting a Leishmania infection. In a pe-
riod of 4 years, 81 dogs that had temporarily
resided in Southern Europe tested positive with
the direct agglutination test (DAT), which is a
highly speciﬁc and sensitive test to diagnose ca-
nine VL (Harith et al.1987, Harrith et al.1989,
Oskam et al. 1996). By combining this number
with the results of the inquiry, it was concluded
that VL is caught by at least 0.027% of the
58,000 dogs yearly visiting Southern Europe.
The negative results of the DAT in all of the 434
dogs that had been in an endemic area but vis-
ited the UUCCA for clinical symptoms not re-
lated to leishmaniasis, leads to the conclusion
that chances are mathematically less than
0.23% that a dog visiting Southern Europe gets
leishmaniasis. Combining all data, it is con-
cluded that Dutch dogs temporarily visiting
Southern Europe have a chance of 0.027% to
0.23% of obtaining canine visceral leishmania-
sis. That the odds are more than 0.027% is
likely because the diagnosis has doubtlessly
been missed in some dogs. However, it is very
likely that the number of dogs in which the di-
agnosis had been missed is relatively small. Al-
most every dog in which a preliminary diagno-
sis of leishmaniasis had been conﬁrmed in our
clinic by serology or cytology of material sent
in by practioners, had subsequently been re-
ferred to our clinic for treatment. Moreover, di-
agnostic tests for canine VL, including cytol-
ogy and DAT, were almost exclusively per-
formed in our clinic. The calculated maximum
of 0.23% seems therefore rational indeed.
The practical signiﬁcance of these ﬁgures is
nevertheless limited for the individual dog. The
odds that a dog obtains leishmaniasis while ac-
companying his owner during a vacation in
Southern Europe is more subtle than 0.027% to
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was made between dogs that had been in a re-
gion with a high or a low degree of infection,
had remained at one location, had traveled
around, nor whether they had stayed there for a
short or longer period of time. These consider-
ations are important when a veterinarian in-
forms a client about the risk of taking a dog on
a vacation abroad. The effect of preventive
measures like the use of insecticide impregnant
collars may also signiﬁcantly reduce the infec-
tion risk for the individual dog (Killick-
Kendrick et al. 1997).
Another interesting aspect of canine VL in non-
endemic areas concerns its possible transmis-
sion from dog to people or from dog to dog in
the absence of sandﬂies. Although direct trans-
mission, probably by the bite of an infected
hamster or by accidental contact with an in-
fected injection needle has been described in a
laboratory technician (Terry et al. 1950), no
cases have been documented of humans di-
rectly infected by dogs in non-endemic coun-
tries. Even in the present study none of the own-
ers and house mates of dogs with VL had a
positive Leishmania titer. This may probably be
ascribed to the low susceptibility of healthy
adult people to a Leishmania infection in com-
parison to dogs (WHO, 1990). Amastigotes
have been detected in saliva and urine of in-
fected patients (Faust & Russell 1957, Hubbert
et al. 1975) and although the uptake of amastig-
otes by an intact gastrointestinal tract is un-
likely, it seems quite possible that they are
picked up by the macrophages in a mucosal le-
sion or bite wound. Mechanical contamination
via biting ﬂies has also been documented (Hub-
bert et al. 1975). Even though the gastrointesti-
nal tract of ticks may harbor infectious pro-
mastigotes (Sherlock & Santos 1964, McKen-
zie 1984), the signiﬁcance of this ﬁnding re-
garding transmission of the diasease remains
questionable as it still has to be seen how these
infectious promastigotes should infect the dog.
Autochtonous cases of canine VL in non-en-
demic countries have been described in Swit-
zerland (Schawalder 1977), Germany (Gothe
1990, Reusch & Reiter 1987), England (Harris
1994), and the Netherlands (Slappendel 1988,
Diaz-Espineira & Slappendel 1997). In the pre-
sent study one dog that had never been in a
Leishmania endemic country tested repeatedly
positive with the DAT. In this dog no parasites
could be demonstrated cytologically. As this
dog did not develop clinical signs of VL, these
test results have to be considered false positive.
In conclusion, the risk for dogs on getting in-
fected with Leishmania when they are accom-
panying the owners to endemic areas during va-
cation is between 0.027% and 0.23%. The risk
for owners in non-endemic areas to get leish-
maniasis from their infected dog seems to be
minimal, although the sample size for detecting
transmission to humans in this study was rather
small.
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Sammanfattning
Risiko for infektion med Leishmania spp. i den ned-
erlandske hundepopulation. 
Leishmania infantum orsakar den viscerala formen
av leishmaniasis (VL) hos människor i södra Europa.
Hunden är huvudreservoar för parasiten. Risken för
hundar som lever i ett icke endemiskt område för
Leishmania, att smittas av infekterade hundar vid
förﬂyttning till ett endemiskt område, och därmed
även utgöra en infektionsrisk för människorna i om-
rådet, har undersökt genom att kombinera resultaten
från en enkätundersökning med resultaten från serol-
ogiska prover. 
Enkäten skickades ut till 1478 slumpmässigt utvalda
familjer i Nederländerna. Av de 59,0% som besva-
rade enkäten hade 28% av familjerna en eller ﬂera
hundar, och 4,8% av dessa hade besökt södra Europa
under sommaren det senaste året. Detta betyder att av
en totalpopulation av 1.200.000 hundar i Nederlän-
derna, löper 58.000 hundar risk för att exponeras för
infektion av Leishmania i södra Europa. 
Under perioden 1990-1992 togs blodprov för serologi
från 1.911 hundar som besökte universitetskliniken i
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leishmaniosis. Fyrahundratrettiofyra av dessa hundar
hade besökt södra Europa under de tidigare åren. In-
gen av dem var serologiskt positiv. Resultaten tyder
på att risken för att infekteras med leishmaniosis un-
der semester i södra Europa är mindre än 0,23%. 
Serologiska prover togs under perioden 1989-1993
på 597 hundar som hade bevistat södra Europa och
som var misstänkta för att ha leishmaniosis. En posi-
tiv titer hittades i 145 av dessa prover, vilket ger en
lägsta infektionsfrekvens på 29 hundar per år i Ned-
erländerna. Fyrtiofyra procent av dessa hundar var
födda i medelhavsländerna och hade importerats till
Nederländerna. Av detta drogs slutsatsen att minst
0,027% av de 58 000 hundar som årligen besökte sö-
dra Europa under semestern infekterades med Leish-
mania. 
För att undersöka risken för människor i nära kontakt
med en infekterad hund att bli smittade med leisman-
iosis, togs serumprover från djurägare till samt män-
niskor sam varit i nära kontakt med 37 infekterade
hundar. Samtliga 112 undersökta prover var serolo-
giskt negativa.
Undersökningen visar att risken för hundar, som
besöker södra Europa, att infekteras med leishmanio-
sis ligger mellan 0,027-0,23 %, samt att risken för
hundägare i ett icke-endemiskt område att infekteras
med leishmaniosis är minimal.
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